# Demonstration of a Digital Care Program for Methamphetamine Use Disorder

> **NCT05206175** · NA · COMPLETED · sponsor: **Affect Therapeutics, Inc.** · enrollment: 100 (actual)

## Conditions studied

- Methamphetamine Abuse

## Interventions

- **OTHER:** Affect Treatment Program for Methamphetamine Use Disorder

## Key facts

- **NCT ID:** NCT05206175
- **Lead sponsor:** Affect Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-14
- **Primary completion:** 2022-11-14
- **Final completion:** 2022-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05206175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05206175, "Demonstration of a Digital Care Program for Methamphetamine Use Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05206175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*